Works matching IS 03125963 AND DT 2021 AND VI 60 AND IP 12
Results: 11
Acknowledgement to Referees.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 12, p. 1489, doi. 10.1007/s40262-021-01087-x
- Publication type:
- Article
Review of Transporter Substrate, Inhibitor, and Inducer Characteristics of Cladribine.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 12, p. 1509, doi. 10.1007/s40262-021-01065-3
- By:
- Publication type:
- Article
Impact of Inflammation on Cytochromes P450 Activity in Pediatrics: A Systematic Review.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 12, p. 1537, doi. 10.1007/s40262-021-01064-4
- By:
- Publication type:
- Article
Clinical Pharmacokinetics and Pharmacodynamics of Cefiderocol.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 12, p. 1495, doi. 10.1007/s40262-021-01063-5
- By:
- Publication type:
- Article
Correction to: Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell Lymphoma.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
A Population Pharmacokinetic Model of Macitentan and Its Active Metabolite Aprocitentan in Healthy Volunteers and Patients with Pulmonary Arterial Hypertension.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 12, p. 1605, doi. 10.1007/s40262-021-01049-3
- By:
- Publication type:
- Article
Exposures of Phenylacetic Acid and Phenylacetylglutamine Across Different Subpopulations and Correlation with Adverse Events.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 12, p. 1557, doi. 10.1007/s40262-021-01047-5
- By:
- Publication type:
- Article
Physiologically Based Pharmacokinetic Modeling of Meropenem in Preterm and Term Infants.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 12, p. 1591, doi. 10.1007/s40262-021-01046-6
- By:
- Publication type:
- Article
Pharmacokinetic Correlates of Once-Monthly Paliperidone Palmitate-Related Adverse Drug Reactions.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 12, p. 1583, doi. 10.1007/s40262-021-01044-8
- By:
- Publication type:
- Article
Influence of CYP2D6 Phenotypes on the Pharmacokinetics of Aripiprazole and Dehydro-Aripiprazole Using a Physiologically Based Pharmacokinetic Approach.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 12, p. 1569, doi. 10.1007/s40262-021-01041-x
- By:
- Publication type:
- Article
Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell Lymphoma.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 12, p. 1621, doi. 10.1007/s40262-021-01039-5
- By:
- Publication type:
- Article